vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

INNOVATIVE INDUSTRIAL PROPERTIES INC is the larger business by last-quarter revenue ($66.7M vs $44.6M, roughly 1.5× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). INNOVATIVE INDUSTRIAL PROPERTIES INC runs the higher net margin — 47.8% vs -90.4%, a 138.2% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -13.1%). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -6.0%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

IIPR vs PACB — Head-to-Head

Bigger by revenue
IIPR
IIPR
1.5× larger
IIPR
$66.7M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+27.0% gap
PACB
13.8%
-13.1%
IIPR
Higher net margin
IIPR
IIPR
138.2% more per $
IIPR
47.8%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-6.0%
IIPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IIPR
IIPR
PACB
PACB
Revenue
$66.7M
$44.6M
Net Profit
$31.8M
$-40.4M
Gross Margin
37.1%
Operating Margin
47.8%
-92.3%
Net Margin
47.8%
-90.4%
Revenue YoY
-13.1%
13.8%
Net Profit YoY
-20.4%
-1802.7%
EPS (diluted)
$1.07
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
PACB
PACB
Q4 25
$66.7M
$44.6M
Q3 25
$64.7M
$38.4M
Q2 25
$62.9M
$39.8M
Q1 25
$71.7M
$37.2M
Q4 24
$76.7M
$39.2M
Q3 24
$76.5M
$40.0M
Q2 24
$79.8M
$36.0M
Q1 24
$75.5M
$38.8M
Net Profit
IIPR
IIPR
PACB
PACB
Q4 25
$31.8M
$-40.4M
Q3 25
$29.3M
$-38.0M
Q2 25
$26.0M
$-41.9M
Q1 25
$31.1M
$-426.1M
Q4 24
$40.0M
$2.4M
Q3 24
$40.2M
$-60.7M
Q2 24
$42.0M
$-173.3M
Q1 24
$39.4M
$-78.2M
Gross Margin
IIPR
IIPR
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
IIPR
IIPR
PACB
PACB
Q4 25
47.8%
-92.3%
Q3 25
45.5%
-101.1%
Q2 25
45.9%
-112.8%
Q1 25
47.4%
-1154.5%
Q4 24
54.7%
-390.1%
Q3 24
54.8%
-160.3%
Q2 24
53.1%
-488.3%
Q1 24
55.7%
-209.6%
Net Margin
IIPR
IIPR
PACB
PACB
Q4 25
47.8%
-90.4%
Q3 25
45.3%
-98.9%
Q2 25
41.4%
-105.4%
Q1 25
43.3%
-1146.8%
Q4 24
52.2%
6.0%
Q3 24
52.6%
-151.9%
Q2 24
52.6%
-481.3%
Q1 24
52.3%
-201.4%
EPS (diluted)
IIPR
IIPR
PACB
PACB
Q4 25
$1.07
$-0.11
Q3 25
$0.97
$-0.13
Q2 25
$0.86
$-0.14
Q1 25
$1.03
$-1.44
Q4 24
$1.35
$-0.44
Q3 24
$1.37
$-0.22
Q2 24
$1.44
$-0.64
Q1 24
$1.36
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$47.6M
$279.5M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$1.8B
$5.3M
Total Assets
$2.4B
$784.1M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
PACB
PACB
Q4 25
$47.6M
$279.5M
Q3 25
$41.9M
$298.7M
Q2 25
$104.9M
$314.7M
Q1 25
$133.3M
$343.1M
Q4 24
$151.2M
$389.9M
Q3 24
$172.4M
$471.1M
Q2 24
$160.9M
$509.8M
Q1 24
$173.5M
$561.9M
Total Debt
IIPR
IIPR
PACB
PACB
Q4 25
$393.7M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IIPR
IIPR
PACB
PACB
Q4 25
$1.8B
$5.3M
Q3 25
$1.9B
$36.1M
Q2 25
$1.9B
$61.5M
Q1 25
$1.9B
$91.6M
Q4 24
$1.9B
$506.6M
Q3 24
$1.9B
$453.1M
Q2 24
$1.9B
$492.7M
Q1 24
$2.0B
$649.0M
Total Assets
IIPR
IIPR
PACB
PACB
Q4 25
$2.4B
$784.1M
Q3 25
$2.3B
$803.2M
Q2 25
$2.3B
$825.5M
Q1 25
$2.4B
$860.8M
Q4 24
$2.4B
$1.3B
Q3 24
$2.4B
$1.5B
Q2 24
$2.4B
$1.5B
Q1 24
$2.4B
$1.7B
Debt / Equity
IIPR
IIPR
PACB
PACB
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
PACB
PACB
Operating Cash FlowLast quarter
$198.2M
$-19.1M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
6.22×
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
PACB
PACB
Q4 25
$198.2M
$-19.1M
Q3 25
$45.6M
$-18.7M
Q2 25
$48.4M
$-29.4M
Q1 25
$54.2M
$-44.1M
Q4 24
$258.4M
$-30.6M
Q3 24
$64.9M
$-45.5M
Q2 24
$64.2M
$-54.3M
Q1 24
$71.6M
$-75.7M
Free Cash Flow
IIPR
IIPR
PACB
PACB
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
IIPR
IIPR
PACB
PACB
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
IIPR
IIPR
PACB
PACB
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
IIPR
IIPR
PACB
PACB
Q4 25
6.22×
Q3 25
1.56×
Q2 25
1.86×
Q1 25
1.75×
Q4 24
6.46×
-12.93×
Q3 24
1.61×
Q2 24
1.53×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIPR
IIPR

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons